Clinical Trial Update: Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subcutaneously administered interleukin-12 in HIV-infected patients with disseminated Mycobacterium avium complex infection has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Mycobacterium Avium Complex Infection

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, Mycobacterium Avium-Intracellulare Infection | Phase 1 | Status: COMPLETED